• Skip to main content

DistilINFO LifeSciences

Weekly round up from Life Sciences Industry.

  • Publications
    • Home
    • DistilINFO HealthPlan
    • DistilINFO HospitalIT
    • DistilINFO IT
    • DistilINFO Retail
    • DistilINFO POPHealth
    • DistilINFO Ageing
    • DistilINFO Life Sciences
    • DistilINFO GovHealth
    • DistilINFO EHS
    • DistilINFO HealthIndia
    • Subscribe
    • Submit Article
    • Advertise
    • Newsletters

Murata: Notice of Acquisition of MIRAISENS, a 3DHaptics Company

Share:

January 7, 2020

Murata Manufacturing Co., Ltd. (TOKYO: 6981) (ISIN: JP3914400001) and MIRAISENS, Inc. (head office: Tsukuba City, Ibaraki Prefecture; CEO: Natsuo Koda; hereafter “MIRAISENS”), which offers haptic solutions technology using 3DHaptics technology*1, have signed an agreement for MIRAISENS to become a wholly-owned subsidiary of Murata Manufacturing. However, the specific terms and conditions of this agreement have not been disclosed.

*1 By combining vibrations of various intensity generated by a device, this technology combines the three senses of “force,” including the feeling of being pulled or pushed, “pressure,” the feeling of touch, firmness and softness, and “tactility,” the feeling of surface textures, thus recreating real sensory feelings.

Demand for tactile experiences has been rising in various markets in recent years. Such markets include the entertainment sector, in which realistic gaming experiences are expected due to the spread of virtual reality and the coming expansion of 5G, and the medical sector, which requires tactile feedback for patients during remote treatment.

MIRAISENS is developing 3DHaptics technology based on “Illusionary Haptics*2,” the world’s first haptic technology established on a neuroscientific basis by the National Institute of Advanced Industrial Science and Technology (Tsukuba head office: Tsukuba City, Ibaraki Prefecture; president: Ryoji Chubachi; hereafter “AIST”).

Want to publish your own articles on DistilINFO Publications?

Send us an email, we will get in touch with you.

*2 Discovered for the first time in the world by Dr. Norio Nakamura at AIST. By generating illusions in the human brain through dermal stimuli, this technology creates a mental illusion.

MIRAISENS’s haptic solutions technology differs from conventional technology based on physical engineering, and lets humans perceive various textures and tactile sensations by generating illusions in the brain through specific stimulation patterns on the skin.

For example, this technology can make it seem as if one were actually feeling the softness or texture of objects expressed as digital content in VR games. MIRAISENS is achieving these outstanding product characteristics with small and low-cost hardware through its original programming and housing design.

Through this acquisition, Murata Manufacturing aims to offer original products and services by combining the device design technology it has cultivated in its sensor and actuator business with the haptic solutions technology owned by MIRAISENS.

Murata Manufacturing’s Chairman of the Board and President Tsuneo Murata said the following about this acquisition:

“I expect that in accordance with the expansion of communications technology such as 5G, there will be a growing number of situations that demand experiences comparable to real human sensory perception. MIRAISENS’s haptic solutions technology, which can reproduce various cognitive experiences, is an amazing technology that conveys the experience of touch in a realistic way amid the increasing digitalization of society. I am very happy that we will be able to work on creating new value by combining MIRAISENS’s technology and the technology held by the Murata Group.”

MIRAISENS CEO Natsuo Koda said the following about this acquisition:

“By receiving Murata Manufacturing’s strong support on the hardware side, we can accomplish the necessary structures for expanding MIRAISENS’s original 3DHaptics technology to various industrial sectors. Along with accelerating the spread of the digital experience business that MIRAISENS has been working on a global scale, I am very much looking forward to greatly innovating research and development in next-generation human machine interface (HMI) technology by drawing on synergies as a member of the Murata Manufacturing Group.”

Source: BusinessWire

Coffee with DistilINFO's Morning Updates...

Sign up for DistilINFO e-Newsletters.

Just a little bit more about you...
PROCEED
Choose Lists
BACK

Related Stories

  • Publication of Definitive Interim Result for Vifor Pharma Tender Offer: CSL Behring AG Declares Offer SuccessfulPublication of Definitive Interim Result for Vifor Pharma Tender Offer: CSL Behring AG Declares Offer Successful
  • Bola Technologies, Inc. and Henry Schein One Announce PartnershipBola Technologies, Inc. and Henry Schein One Announce Partnership
  • Propeller Health Adds Community Pharmacy Chains to Its AppPropeller Health Adds Community Pharmacy Chains to Its App
  • Centre Partners Acquires Majority Stake in One World FitnessCentre Partners Acquires Majority Stake in One World Fitness
  • Global M&A hit hard in first quarter, with trade war and cooling growth taking toll on AsiaGlobal M&A hit hard in first quarter, with trade war and cooling growth taking toll on Asia
  • Brazil-Based Omnichannel Messaging Service Startup Take Blip Raises USD 70 Million in Series BBrazil-Based Omnichannel Messaging Service Startup Take Blip Raises USD 70 Million in Series B
  • Banner Health Expands Ambulatory & Acute Virtual Care Services to PatientsBanner Health Expands Ambulatory & Acute Virtual Care Services to Patients
  • COVID-19 Trend Report Reveals Which States Have Reached or Passed their PeaksCOVID-19 Trend Report Reveals Which States Have Reached or Passed their Peaks

Trending This Week

Sorry. No data so far.

About Us

DistilINFO is media company that publishes Industry news, views and Interviews. We distil the information for you – saving time and keeping you up to date on your interest areas.

More About Us

Follow Us


Useful Links

  • Subscribe
  • Contact
  • Advertise
  • Privacy Policy
  • Terms of Service
  • Feedback

All Publications

  • DistilINFO HealthPlan Advisory
  • DistilINFO HospitalIT Advisory
  • DistilINFO IT Advisory
  • DistilINFO Retail Advisory
  • DistilINFO POPHealth Advisory
  • DistilINFO Ageing Advisory
  • DistilINFO Life Sciences Advisory
  • DistilINFO GovHealth Advisory
  • DistilINFO EHS Advisory
  • DistilINFO HealthIndia Advisory

© DistilINFO Publications